Moderna’s COVID Vaccine Gains Full FDA Approval for Children Aged 6 Months and Older
The FDA has granted full approval for Moderna's COVID-19 vaccine, Spikevax, for children aged 6 months to 11 years at increased risk, expanding beyond emergency use authorization, with availability expected for the 2025-26 season.